{
  "retracted": false,
  "timestamp": 1554940800000,
  "updates": [
    {
      "timestamp": 1555008188516,
      "identifier": {
        "doi": "10.1371/journal.pone.0215109"
      },
      "type": "expression_of_concern"
    }
  ],
  "identifier": {
    "doi": "10.1371/journal.pone.0028841"
  },
  "journal": "PLOS ONE",
  "publisher": "Public Library of Science (PLoS)",
  "title": "Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors"
}
